Patents Assigned to Weizmann Institute of Science
-
Patent number: 12131498Abstract: A way to design a codebook for estimating the type of a molecule at a particular location in a fluorescence microscopy image makes use of one or both of (1) knowledge of the non-uniform prior distribution of molecule types (i.e., some types are known a priori to occur more frequently than others) and/or knowledge of co-occurrence of molecule types at close locations (e.g., in a same cell); and (2) knowledge of a model of the (e.g., random) process that yields the intensities that are expected at a location when a molecule with a particular subset of markers (i.e., a molecule of a type that has been assigned a codeword that defines that subset) is present at that location. The codebook design may provide experimental efficiency by reducing the number of images that need to be acquired and/or improve classification or detection accuracy by making the codewords for different molecule types more distinctive.Type: GrantFiled: April 27, 2022Date of Patent: October 29, 2024Assignees: The Broad Institute, Inc., Massachusetts Institute of Technology, Yeda Research and Development Co. LTD. of Weizmann Institute of Science, National University of Ireland MaynoothInventors: Mehrtash Babadi, Luca D'Alessio, Muriel Medard, Ken Duffy, Yonina Eldar, Litian Liu
-
Patent number: 10933134Abstract: A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).Type: GrantFiled: March 16, 2018Date of Patent: March 2, 2021Assignees: Memorial Sloan Kettering Cancer Center, Yeda Research and Development Co. Ltd., at the Weizmann Institute of ScienceInventors: Jonathan Coleman, Philip A. Watson, Kwanghee Kim, Avigdor Scherz
-
Patent number: 10463870Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.Type: GrantFiled: August 22, 2016Date of Patent: November 5, 2019Assignee: Yeda Research & Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Yiftach Roth, Vadim Chudnovsky, Noach Safra, David Hazani, Abraham Zangen
-
Patent number: 10265412Abstract: The present invention relates in general to the field of enzyme replacement therapy, and specifically to chimeric proteins including protein hormone-therapeutic protein conjugates and fusion proteins, wherein the protein hormone is selected from a protein hormone which is able to cross the blood brain barrier, for the treatment of lysosomal storage diseases, compositions of the same and to methods of use thereof.Type: GrantFiled: February 6, 2007Date of Patent: April 23, 2019Assignees: Ramot at Tel-Aviv University Ltd., Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Naftali Stern, Ruth Navon, Anthony Futerman, Ari Zimran, Etty Osher
-
Patent number: 10238113Abstract: The present invention relates to regulation of ureide levels for optimal plant survival during nutrient remobilization such as occurs during normal growth, dark stress and senescence. Plants can be genetically engineered or selected using a suitable gene marker to have enhanced ureide accumulation. The present invention further provides methods of protecting plants, or extending the shelf life of fresh plant produce by application of exogenous ureides.Type: GrantFiled: March 12, 2015Date of Patent: March 26, 2019Assignees: Yeda Research and Development Co. Ltd. at The Weizmann Institute of Science, Ben-Gurion University of The Negev research and Development AuthorityInventors: Robert Fluhr, Moshe Sagi
-
Publication number: 20190028641Abstract: According to one aspect, the present description relates to a system for high resolution imaging of an object comprising a fiber bundle (1) comprising an array of optical fiber cores (A), said fiber bundle being adapted to receive a plurality of light beams issued from spatially incoherent point sources of an object; the system further comprises a two-dimensional detector (240) with a detection plane, located at a proximal end of the fiber bundle, adapted to receive speckle patterns, each speckle pattern resulting from the transmission of one of said light beams through at least a plurality of the fiber bundle cores, the ensemble of speckle patterns detected by the two-dimensional detector forming a multiple speckles image; and a processing unit (250) adapted to determine an image of the object from said multiple speckles image.Type: ApplicationFiled: December 17, 2015Publication date: January 24, 2019Applicants: Université d'Aix-Marseille, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNR S, Ecole Centrale de Marseille (ECM), Weizmann Institute of Science (WIS)Inventors: Hervé Rigneault, Esben Andresen, Amir Porat, Dan Oron, Ori Katz, Sylvain Gigan
-
Patent number: 10159724Abstract: The present invention relates to a method for treating or preventing pathogenic infections in a subject having Cystic Fibrosis, COPD, and/or an open wound. This method involves selecting a subject having Cystic Fibrosis, COPD, and/or an open wound and administering to the selected subject a ceramidase under conditions effective to reduce ceramide and to treat or prevent the pathogenic infection. The method also involves the use of a ceramidase in combination with other drugs to reduce infection, reduce ceramide, or improve lung function in Cystic Fibrosis, COPD, and/or open wound patients.Type: GrantFiled: October 5, 2016Date of Patent: December 25, 2018Assignees: Icahn School of Medicine at Mount Sinai, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Edward H. Schuchman, Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung
-
Publication number: 20180223302Abstract: The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.Type: ApplicationFiled: June 22, 2016Publication date: August 9, 2018Applicants: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Yeda Research and Development Co. Ltd., at the Weizmann Institute of ScienceInventors: Arren BAR-EVEN, Tobias ERB, Steffen LINDNER, Philippe MARLIERE, Dan S. TAWFIK
-
Patent number: 10029113Abstract: A system and methods for transcranial magnetic stimulation, the system including a helmet, a positioning portion, a stimulator and a cooling system, are disclosed. The helmet includes a coil for deep brain magnetic stimulation. The coil has a base portion, and return portions, which may include a protruding return portion and a contacting return portion. The coil is designed to minimize unintended stimulation of portions of the brain, while reducing accumulation of surface charges. The coil is stimulated at several locations and/or at different times so as to focus the electrical field on a specific deep neuronal structure.Type: GrantFiled: September 10, 2015Date of Patent: July 24, 2018Assignees: BRAINSWAY, LTD., YEDA RESEARCH & DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICESInventors: Abraham Zangen, Yiftach Roth, Pedro C. Miranda, David Hazani, Mark Hallett
-
Patent number: 9966458Abstract: The present invention relates to a method and a device for providing a current of spin-polarized electrons. More particularly, the present invention is suited for use in spin electronics or detection of spin-polarized electrons.Type: GrantFiled: June 10, 2016Date of Patent: May 8, 2018Assignees: Westfälische Wilhelms Universität Münster, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Benjamin Göhler, Volker Hamelbeck, G. Friedrich Hanne, Helmut Zacharias, Ron Naaman, Tal Zvi Markus
-
Patent number: 9867576Abstract: Exemplary embodiments of a system and method can be provided for measuring a level and/or details of how engaging, effective or memorable a stimulus that may be based on information associated with one or more subjects' neuronal, physiological and/or behavioral responses to the stimulus. In addition, an exemplary embodiment of a computer-accessible medium containing executable instructions thereon can also be provided which can be executed by a processing arrangement. For example, when the processing arrangement executes the instructions, the processing arrangement can be configured to, e.g., receive neuronal, physiological and/or behavioral data one or more subjects being presented with stimuli, determine further data associated with a measure of inter-subject similarity of the neuronal, physiological and/or behavioral data, and identify particular portions of the stimuli that meet a pre-determined criteria relating to the further data associated with the measure of inter-subject similarity.Type: GrantFiled: November 9, 2015Date of Patent: January 16, 2018Assignees: NEW YORK UNIVERSITY, YEDA RESEARCH AND DEVELOPMENT CO., LTD. AT THE WEIZMANN INSTITUTE OF SCIENCEInventors: Uri Hasson, Rafi Malach, David Heeger
-
Patent number: 9802989Abstract: An isolated novel oil globule protein encoded by a polynucleotide sequence is provided together with a composition which includes the isolated protein. A transgenic organism transformed by a polynucleotide encoding a protein which at least partially comprises the amino acid sequence of the novel oil globule protein is also provided. The invention also provides a method for producing or enhancing the production of a carotenoid such as astaxanthin, which is an oil globule constituent.Type: GrantFiled: August 30, 2011Date of Patent: October 31, 2017Assignees: Ben Gurion University of the Negev Research and Development Authority, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Sammy Boussiba, Ehud Peled, Uri Pick, Aliza Zarka, Stefan Lou, Meira Weiss
-
Patent number: 9631175Abstract: A method of generating neural and glial cells is provided. The method comprising growing human stem cells under conditions which induce differentiation of said human stem cells into the neural and glial cells, said conditions comprising the presence of retinoic acid and an agent capable of down-regulating Bone Morphogenic Protein activity.Type: GrantFiled: July 11, 2014Date of Patent: April 25, 2017Assignee: Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Michel Revel, Judith Chebath, Michal Izrael, Rosalia Kaufman
-
Patent number: 9492514Abstract: The present invention relates to a method for treating or preventing pathogenic infections in a subject having Cystic Fibrosis, COPD, and/or an open wound. This method involves selecting a subject having Cystic Fibrosis, COPD, and/or an open wound and administering to the selected subject a ceramidase under conditions effective to reduce ceramide and to treat or prevent the pathogenic infection. The method also involves the use of a ceramidase in combination with other drugs to reduce infection, reduce ceramide, or improve lung function in Cystic Fibrosis, COPD, and/or open wound patients.Type: GrantFiled: May 31, 2013Date of Patent: November 15, 2016Assignees: Icahn School of Medicine at Mount Sinai, Universitaet Duisberg-Essen, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Edward H. Schuchman, Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung
-
Patent number: 9421393Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.Type: GrantFiled: December 11, 2009Date of Patent: August 23, 2016Assignee: Yeda Research & Development Co., Ltd. at the Weizmann Institute of ScienceInventors: Yiftach Roth, Vadim Chudnovsky, Noach Safra, David Hazani, Abraham Zangen
-
Patent number: 9391285Abstract: The present invention relates to a method and a device for providing a current of spin-polarized electrons. More particularly, the present invention is suited for use in spin electronics or detection of spin-polarized electrons.Type: GrantFiled: February 3, 2012Date of Patent: July 12, 2016Assignees: Westfälische Wilhelms Universität Münster, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Benjamin Göhler, Volker Hamelbeck, G. Friedrich Hanne, Helmut Zacharias, Ron Naaman, Tal Zvi Markus
-
Patent number: 9345753Abstract: Compositions and methods for prevention and treatment of Alzheimer's disease utilize a combination of amyloid-beta protein or a fragment thereof and a heat shock protein or a fragment thereof.Type: GrantFiled: January 15, 2009Date of Patent: May 24, 2016Assignees: YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE, BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: Alon Monsonego, Irun R. Cohen
-
Patent number: 9179858Abstract: Exemplary embodiments of a system and method can be provided for measuring a level and/or details of how engaging, effective or memorable a stimulus that may be based on information associated with one or more subjects' neuronal, physiological and/or behavioral responses to the stimulus. In addition, an exemplary embodiment of a computer-accessible medium containing executable instructions thereon can also be provided which can be executed by a processing arrangement. For example, when the processing arrangement executes the instructions, the processing arrangement can be configured to, e.g., receive neuronal, physiological and/or behavioral data one or more subjects being presented with stimuli, determine further data associated with a measure of inter-subject similarity of the neuronal, physiological and/or behavioral data, and identify particular portions of the stimuli that meet a pre-determined criteria relating to the further data associated with the measure of inter-subject similarity.Type: GrantFiled: March 5, 2009Date of Patent: November 10, 2015Assignees: New York University, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Uri Hasson, Rafi Malach, David Heeger
-
Patent number: 9180305Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.Type: GrantFiled: December 11, 2008Date of Patent: November 10, 2015Assignee: Yeda Research & Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Yiftach Roth, Abraham Zangen, Vadim Chudnovsky, Noach Safra, David Hazani
-
Publication number: 20150307883Abstract: Monomeric and multimeric aptamers are provided. Also provided are pharmaceutical compositions which comprise same and methods of using same.Type: ApplicationFiled: October 27, 2013Publication date: October 29, 2015Applicant: Yeda Research and Development Co. Ltd. at Weizmann Institute of ScienceInventors: Yosef YARDEN, Michael SELA, Georg MAHLKNECHT, Ruth MARON, Bilha SCHECHTER